Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ADIR describes compunds with high affinity for 5-HT2C and/or 5-HT3C receptors

Aug. 9, 1996

No Comments

Lidocaine nasal drops shown effective for fast migraine pain relief

Aug. 9, 1996

No Comments

5-HT1 agonists described by Merck & Co.

Aug. 9, 1996

No Comments

Actiq to undergo phase III clinical trials

Aug. 9, 1996

No Comments

Menarini and Lilly sign comarketing agreement

Aug. 9, 1996

No Comments

Bifemelane claimed for cerebrovascular disorders treatment

July 26, 1996

No Comments

Research supports role of testosterone in pathogenesis of stroke

July 26, 1996

No Comments

Immunex issued U.S. patent for Lerk-7

July 26, 1996

No Comments

ERT therapy enhances clinical response to tacrine in Alzheimer's patients

July 26, 1996

No Comments

CP-122638: Pfizer's potential treatment for non-migraine emesis

July 26, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

ADIR describes compunds with high affinity for 5-HT2C and/or 5-HT3C receptors

Lidocaine nasal drops shown effective for fast migraine pain relief

5-HT1 agonists described by Merck & Co.

Actiq to undergo phase III clinical trials

Menarini and Lilly sign comarketing agreement

Bifemelane claimed for cerebrovascular disorders treatment

Research supports role of testosterone in pathogenesis of stroke

Immunex issued U.S. patent for Lerk-7

ERT therapy enhances clinical response to tacrine in Alzheimer's patients

CP-122638: Pfizer's potential treatment for non-migraine emesis

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

Neurology/psychiatric RSS

Neurology/psychiatric
RSS